APRAMEYA (APRAMEYA) fundamentals
APRAMEYA is a listed company, part of the Trading sector, listed on the NSE as APRAMEYA (ISIN INE0LQG01010). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What APRAMEYA does
Aprameya Engineering Limited is engaged in the business of installation, setting up and maintenance of intensive care units (ICU), neonatal intensive care units (NICU), pediatric intensive care units (PICU), operation theater and prefabricated structure ward (Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis. The Company also supplies healthcare equipment and diagnostic equipment to private hospitals, government hospitals and medical practitioners. It operates in two segments: trading of medical support equipment (trading sales) and supplies for infra projects of healthcare sectors (turnkey project supplies). Its solutions include hospital design solution, turnkey healthcare solution, specialty driven turnkey solution, medical equipment solution and service & comprehensive annual maintenance contracts (CAMC) solution. Its hospital design solutions include architecture design, structural design, M.E.P design and interior design.
Valuation and market data
| Last close | ₹116.00 |
|---|---|
| Market capitalisation | ₹222 crore |
| Enterprise value | ₹224 crore |
| P/E (TTM) | 0.00 |
| Price to book | 3.19 |
| Price to sales (TTM) | 0.00 |
| Book value per share | ₹36.35 |
| Dividend yield | 0.00% |
| Sector | Trading |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹56 crore | ₹7 crore | ₹5 crore | 2.68 |
| Mar 2025 | ₹136 crore | ₹22 crore | ₹16 crore | 9.31 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 74.0% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.7% |
| Retail and others | 25.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.